BlueLinx Holdings Inc. director Kim S. Fennebresque filed a Form 144 notice of proposed sale on November 5, 2026, disclosing plans to sell 4,929 shares of BlueLinx common stock through Charles Schwab & Co., Inc.

Key Highlights

  • Proposed sale: Director Kim S. Fennebresque intends to sell 4,929 shares of BlueLinx Holdings Inc. common stock.
  • Aggregate market value: The proposed sale carries an aggregate market value of $367,161.00, according to the filing.
  • Exchange and shares outstanding: The securities are listed on the NYSE; total shares outstanding are reported as 7,864,549.
  • Approximate sale date: The filing lists an approximate date of sale of November 5, 2026, through broker Charles Schwab & Co., Inc. in Westlake, TX.
  • Prior sales: The filing discloses a sale of 34,138 shares on August 6, 2026, with gross proceeds of $2,872,712.00 during the past three months.
  • Acquisition history: The shares to be sold were acquired via restricted stock unit grants from the issuer: 3,003 shares on May 19, 2022, and 1,926 shares on May 19, 2023, both classified as equity compensation.

Proposed Rule 144 Sale by BlueLinx Holdings Director

According to the Form 144 notice filed with the U.S. Securities and Exchange Commission on November 5, 2026, BlueLinx Holdings Inc. (NYSE:BXC) director Kim S. Fennebresque has provided notice of a proposed sale of 4,929 shares of common stock. The filing identifies the broker as Charles Schwab & Co., Inc., located at 3000 Schwab Way, Westlake, TX 76262. The aggregate market value of the proposed sale is listed as $367,161.00, and the approximate date of sale is given as November 5, 2026.

The filing discloses that the shares to be sold were acquired through restricted stock unit grants from the issuer. Specifically, 3,003 shares were acquired on May 19, 2022, and 1,926 shares were acquired on May 19, 2023, both identified as equity compensation transactions. The filing does not indicate that any of the securities were received as gifts.

As required under Form 144, the filing also reports securities sold by the same person during the preceding three months. According to the disclosure, Fennebresque sold 34,138 shares of BlueLinx common stock on August 6, 2026, generating gross proceeds of $2,872,712.00. The total shares of BlueLinx common stock outstanding are reported as 7,864,549. The filing was signed by Mr. Kim Fennerbresque and dated November 5, 2026.

What Was Disclosed

A Form 144 notice filed November 5, 2026, discloses BlueLinx Holdings director Kim S. Fennebresque's proposed sale of 4,929 common shares valued at $367,161.00, along with a prior sale of 34,138 shares on August 6, 2026, for gross proceeds of $2,872,712.00.